Sign In
Free Newsletter
BeiGene cuts ribbon on $800M Hopewell hub
Gov. Phil Murphy and other officials were on hand to celebrate the new manufacturing and clinical R&D center. The company boasts one of the industry’s deepest oncology pipelines, addressing 80% of the world’s cancers.
Biocon Biologics establishes North American HQ in Bridgewater
Company leaders say the new headquarters will house both commercial and administrative functions for the organization, positioning it for future growth.
Annual BioNJ dinner celebrates innovation, life sciences
Gov. Phil Murphy and Insmed CEO Will Lewis delivered remarks at the gathering, which drew its largest crowd yet of industry leaders, representatives and key stakeholders.
J&J to acquire cancer drug developer Ambrx for $2B
According to the New Brunswick-based buyer, the addition of the clinical-stage biopharmaceutical company presents a distinct opportunity to design, develop and commercialize targeted oncology therapeutics.
Bristol Myers Squibb says billion-dollar acquisitions will enhance neuroscience, cancer care
The biopharmaceutical company's play for Karuna Therapeutics will help it harness the "tremendous opportunities in neuroscience," while the addition of RayzeBio Inc. is set to bolster its "increasingly diversified oncology portfolio."
Hepion Pharmaceuticals CEO steps down amid restructuring
In addition to cutting operational costs by about 60%, the Edison-based biopharmaceutical company is looking at options such as an acquisition or merger.
Timber Pharmaceuticals to be acquired by Danish giant in $36M deal
LEO Pharma will add the Warren-based clinical-stage biopharma company, which is focused on the development and commercialization of treatments for rare and orphan dermatologic diseases.
BioCentriq, Cytiva receive funding to accelerate gene therapy development
According to Emmanuel Abate, president, Genomic Medicine, Cytiva, “[C]ollaborations are essential to solve the challenges of bringing future therapeutics to market."
Enzene Biosciences bringing biomanufacturing facility, 300 jobs to Hopewell
“Yet another Indian biopharma company has established itself in the state, demonstrating the strength of the New Jersey-India economic partnership,” said Wesley Mathews, president and CEO of Choose New Jersey.
PTC Therapeutics CEO Peltz retires from company he founded
Announcing the change in leadership, the company noted that under Dr. Stuart Peltz it has grown from a research organization with expertise in the control of RNA processes to a publicly traded, integrated, global biopharmaceutical company.
BeiGene reaches milestone at $700M Hopewell facility
Eleven months after breaking ground, the biopharmaceutical company laid the last piece of structural steel for its new manufacturing and R&D site at the Princeton West Innovation Campus.
Biopharmaceutical company signs lease to relocate HQ to NJ
CBRE announced Intercept Pharmaceuticals, which focuses on developing drugs to treat chronic liver disease, will move its operations from Manhattan to Morristown.
